{"id":"NCT01376245","sponsor":"GlaxoSmithKline","briefTitle":"A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD","officialTitle":"A 24-week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder Delivered Once Daily Via a Dry Powder Inhaler Compared With Placebo in Subjects of Asian Ancestry With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2012-09","completion":"2012-09","firstPosted":"2011-06-20","resultsPosted":"2014-01-28","lastUpdate":"2017-01-11"},"enrollment":646,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"fluticasone furoate/vilanterol","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"fluticasone furoate/vilanterol","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to investigate the efficacy and safety of fluticasone furoate/vilanterol Inhalation Powder compared with placebo over a 24 weeks treatment period in subjects of Asian ancestry with Chronic Obstructive Pulmonary Disease (COPD).","primaryOutcome":{"measure":"Mean Change From Baseline in Clinic Visit Pre-dose Trough FEV1 at Day 169","timeFrame":"Baseline to Day 169","effectByArm":[{"arm":"Placebo","deltaMin":-0.027,"sd":0.0184},{"arm":"FF/VI 50/25 µg OD","deltaMin":0.113,"sd":0.0183},{"arm":"FF/VI 100/25 µg OD","deltaMin":0.152,"sd":0.0181},{"arm":"FF/VI 200/25 µg OD","deltaMin":0.167,"sd":0.0182}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":20},"locations":{"siteCount":34,"countries":["China","Philippines","South Korea","Taiwan"]},"refs":{"pmids":["25830381"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":162},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Pyrexia","Cough","Hypertension"]}}